Find your next paid study

~$10 – $1,125

Actual pay is set by the research site.

Josh CislerNCT07548125

Metastatic Uveal MelanomaCutaneous MelanomaColorectal Cancer+1 more

A Phase 1/2 Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

This is a Phase 1/2, multi-center, open-label basket study designed to evaluate the safety and anti-tumor activity of IDE196 in patients with solid tumors harb…

IDEAYA BiosciencesNCT03947385

~$150 – $4,200

Actual pay is set by the research site.

Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures

The purpose of this study is to evaluate outcomes in patients treated with iFuse TORQ TNT for pelvic fragility fractures.

Fracture; PelvicInsufficiency FracturesFragility Fracture+3 more

~$10 – $1,050

Actual pay is set by the research site.

SI-BONE, Inc.NCT07530497

CancerBreast CancerColorectal Cancer+3 more

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

The purpose of this study is to determine the effectiveness of a digital health program called AYA STEPS, which is designed to help adolescent and young adult …

Duke UniversityNCT06371768

Actual pay is set by the research site.

A Phase 1, Randomized, Participant- and Investigator-Blinded, Placebo Controlled, Single-Dose and Multiple-Ascending Dose Study of Orally Administered LY5625573 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy Participants, Including Japanese and Chinese Populations, and in Participants With Elevated C-Reactive Protein

The purpose of this study is to learn if LY5625573 is safe and how well it is tolerated in healthy participants, including Japanese and Chinese participants, a…

C-Reactive Protein

Eli Lilly and CompanyNCT07867340

~$500 – $11,250

Actual pay is set by the research site.

Phase 3

RASolute 305: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (Modified FOLFIRINOX or Gemcitabine Plus Nab-Paclitaxel) With or Without Zoldonrasib (RMC-9805) as First-line Treatment in Patients With Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma

The purpose of this study is to evaluate the efficacy of an investigational RAS(ON) inhibitor administered in combination with chemotherapy compared to placebo…

Pancreatic CancerPancreatic Cancer MetastaticPDAC+5 more

Revolution Medicines, Inc.

~$50 – $2,100

Actual pay is set by the research site.

[18F]Radiocaine: Radiation and Radiochemical Safety

This is a Phase 1, single-center, open-label study evaluating the safety, biodistribution, and radiation dosimetry of Radiocaine™, an investigational fluorine-…

Healthy Subjects

Lutroo Imaging LLCNCT07081217

~$500 – $10,500

Actual pay is set by the research site.

Empyema, PleuralPleural Infection

Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas

Infections of the pleural space are common, and patients require antibiotics and chest drain placement to evacuate the chest from the infected fluid. Chest dra…

Vanderbilt University Medical CenterNCT06427538

Actual pay is set by the research site.

Long COVIDBrain FogCognitive Impairment+2 more

Technique to Enable Return-to-Work by Employees With Long COVID Brain Fog

This study will compare two approaches to cognitive rehabilitation in adults with long COVID with persistent, mild to moderate, cognitive impairment. One appro…

University of Alabama at BirminghamNCT06095297

Actual pay is set by the research site.

Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more

A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule, in Subjects With Unresectable, Locally Advanced, or Metastatic Solid Tumors That Are Antigen-rich (START-001)

This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent and in co…

Marengo Therapeutics, Inc.

~$150 – $4,200

Actual pay is set by the research site.

Multi-center Prospective Evaluation of the Clinical Utility of Endoscopic Submucosal Dissection (ESD) in the Western Population

The aim of this multi-center study is to prospectively document the clinical utility of ESD.

Endoscopic Submucosal Dissection

University of FloridaNCT02989818

Actual pay is set by the research site.

Tissue Expander Based Breast Reconstruction

A Prospective Randomized Trial of Local Antibiotic Carriers in Tissue Expander-Based Breast Reconstruction

Infections after tissue expander breast reconstruction can lead to pain, additional surgeries, and loss of the reconstruction. This study will compare two type…